BOOST BIOPHARMA
LIVE

Serial Number

97203987

Owner

Boost Biopharma, Inc.

Attorney

Paul Sennott

Filing Date

Jan 5, 2022

Add to watchlist:

No watchlists yet
View on USPTO

BOOST BIOPHARMA Trademark

Serial Number: 97203987

BOOST BIOPHARMA is a trademark filed by Boost Biopharma, Inc. on January 5, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Boost Biopharma, Inc. (2 trademarks)

251 Little Falls Drive
Wilmington, DE 19808

Entity Type: 03

Trademark Details

Filing Date

January 5, 2022

Registration Date

Not Registered

Goods & Services

biological and chemical preparations, and substances, comprising nucleic acids and sequences thereof, amino acids and sequences thereof, peptides, proteins, or combinations of the forgoing, for the development of vaccines for scientific and medical purposes; Nucleic acids and proteins in raw material form for scientific and medical purposes

vaccines, nucleic acid sequences and chemical reagents for medical and veterinary purposes, and protein arrays for medical diagnostic purposes; pharmaceutical and biological preparations and substances, comprising nucleic acids, amino acids, peptides, proteins, or combinations of these, for the diagnosis, prevention, and treatment of bacterial, viral, and parasitic infectious disease, and cancer, for use in connection with humans and animals; pharmaceutical and biological products, namely, diagnostic products, prophylactic products, therapeutic products, vaccines and antibodies for bacterial, viral, and parasitic infectious disease, and vaccines and antibodies for cancer, for use in connection with humans and animals for medical or veterinary purposes; diagnostic preparations for use in connection with humans and animals for medical or veterinary purposes; diagnostic products being diagnostic preparations for use in connection with humans and animals for medical or veterinary purposes

Medical and pharmaceutical research and development of vaccines, nucleic acids, and proteins for use in connection with humans and animals; Medical and pharmaceutical research and development of medical diagnostics for use in connection with humans and animals; Medical and pharmaceutical research and development of vaccine platform technologies; Medical and pharmaceutical research and development of proteins and nucleic acids; Medical and pharmaceutical research and development of medical diagnostics; biomedical research services; pharmaceutical and biological product development services; pharmaceutical and biological product development consulting

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 15, 2026 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 15, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 28, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 28, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 22, 2023 RCSC
ASSIGNED TO EXAMINER
Dec 6, 2023 DOCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 17, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 17, 2023 GNSL
SUSPENSION LETTER WRITTEN
Apr 17, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 15, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 14, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 14, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 14, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 14, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 14, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 11, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 10, 2022 NWOS
NEW APPLICATION ENTERED
Jan 8, 2022 NWAP